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Abstract. 
The PSA doubling time is usually calculated from measured PSA values with an inadequate  
formula that tacitly assumes the absence of that process, which it is supposed to reveal. We 
present a modified calculational procedure which is optimized to unveil a weak second 
exponential process in the presence of a strong first one, using  early screening data. The 
notion of Break Even Time (BET) indicates the stages of the processes. 
 
We assume that four or more measured Prostate-Specific Antigen (PSA) levels have been 
caused by two simultaneous independent exponential processes with different characteristic 
doubling times, DT1 and DT2, the latter being of our main interest. We do not assume any 
previous knowledge of the stages of these processes, the expected results for the DTs shall be 
independent of them. 
The time-dependent PSA concentration is then of the form  PSA(t) = a eα t + b eβ t , with the 
relations  DT1 = ln(2) /α and  DT2 = ln(2) /β.  The constants α and β are thus characteristic 
for the producing cells, whereas a and b depend on the number of acting cells and on various, 
mostly unknown, efficiencies. If the first process alone would be in action (b=0), then the 
PSA(t) curve would, on a logarithmic scale, be a straigth line with a slope characteristic for 
DT1 . From two points at t and t0 we derive the “common formula”  
DT(t) = (t – t0) log(2)/(log(PSA(t)) – log(PSA(t0))).  
 
If this formula is uncautiously used in the case, where two competing processes are present, 
the value obtained for DT(t) becomes misleading, since it has no more an interpretable 
significance with repect to the result of our interest.Due to the mathematical property that  
DT(t) → DT2  for t → ∞  (when β > α), the result of DT(t)  correctly approaches DT2, but at 
a later time, possibly whem it is no more urgently needed. It is especially unspecefic at the 
interesting moment when the second process starts to become visible.We may even suspect, 
that this deficiency, which causes enhanced artifacts in the PSADT results, contributes to the 
controversial interpretations concerning the benefit of  PSADT knowledge at all. 
Our approach is, to search for the curve PSA(t) which is best adapted to the measured PSA 
data, and we extract at once the four values of  a, α, b, β,  which in turn are used for practical 
conclusions. See the Fig. 1. 
We expect, that the value of β has a high specifity for the second process, by design, and that 
it is fairly independent, as well of the properties of the first process as of their stages, by the 
conduct of the formal procedure. 
For an indicator of of the stages of the processes, we may define the time, when the second 
process has grown so strong as to contribute the same amount of PSA, as does the first one, 
i.e. half of the total. Calling this time “BET” = Break Even Time, we find 
BET = 2.30 × log10(a/b) / (β-α) . This formula makes use of information on the relative 
developpment stage of the cell ensembles. Since the ratio (a/b) enters, we expect that common 
unknown factors in the two processes cancel and the result thus  becomes more stable. We 
may think of partly using the first process as a calibration for the second one. This emphasizes 
the necessity of the early measurements (in our case, at  t = 0 and  54 months). 
The sensitivity and the reliability of the result for DT2 is studied by answering the question: 
“Could the second process have been discovered earlier, based on the data after 3, 4 or 5 PSA 
measurements already ?” 
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The points representing the values of the 3 earliest PSA measurements are found to well lay 
on a straight line, considering an uncertainty of  ± 4 % (std, normal)  indicated by the size of 
the circles in Fig. 1.  This is characteristic for one single exponential process. 
The 4th point (at t = 105 months) clearly deviates from a straight line and thus hints at a 
second process. The result of our analysis yields the parameters of this process, and predicts 
the time (BET), when it will have reached an equal PSA-production power to the first one. 
The 5th and 6th measurement confirm the the results for DT2 and BET. A criterion for the 
applicability of the function PSADT(t) and thus of the method proposed here, is provided 
automatically in each single case by the goodness-of-fit result of the least squares analysis. 
 
As a comparison we also give the values calculated with the common formula. See. Fig. 2. 
With an official PSADT calculater published in the internet, a misleading result which 
exceeds our DT2 by a factor of 5 has been found.  
 
In order to obtain a useful tool from our procedure, DT2 and BET have to be calibrated versus 
diagnostic findings. Due to the formal stability of these notions and their direct significance in 
terms of the more general model with two exponentials, we may expect more strict 
correlations than the ones obtained with the presently used dynamic parameters. 
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FIGURE CAPTIONS 
 
 
 
Fig.1. Evidence for two exponential processes. Break Even Time BET determined. 
The curve is a weighted least squares fit of the function PSA(t) to a real patient’s PSA data 
points. It is the sum of the  two straigth lines that reveal the two exponential processes. They 
are widely different in their original strengths and their slopes. At time t = BET, the processes 
are of equal strenth.Their Doubling Times  DT1 = 66 months, DT2 = 7 months, and BET = 
117 months arise in turn as a result from the least squares procedure. The “common formula” 
applied to the latest two points would yield the irrelevant value of DT(116) = 18.5 months. 
 
 
 
Fig. 2. How well is the Doubling Time DT2 predicted after 4, 5 or 6 PSA measurements ? 
Already with the 4th measurement at t = 105 months, a second process is identified. Its 
doubling time DT2 is estimated to be 7.5 ± 6.4 months (std) with a BET of  t = 120 months. 
The later measurements confirm this finding with improved accuracy. The “common 
formula” yields the values labelled “Common F”. They do not show convergence towards an 
interpretable value (yet). 
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FIGURE 1 of  the paper “PSA Dynamics traditionally evaluated with an inadequate formula” 
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FIGURE 2 of the paper “PSA Dynamics traditionally evaluated with an inadequate formula” 
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